Durability of peginterferon alfa-2b treatment at 5 years in patients with hepatitis B e antigen-positive chronic hepatitis B-Reference-Cited by-同舟云学术

Durability of peginterferon alfa-2b treatment at 5 years in patients with hepatitis B e antigen-positive chronic hepatitis B

Published:2010-02-01 Issue:6 Volume:51 Page:1945-1953
ISSN:0270-9139
Container-title:Hepatology
language:en
Short-container-title:Hepatology

Author:

Wong Vincent Wai-Sun,Wong Grace Lai-Hung,Yan Kenneth Kar-Lung,Chim Angel Mei-Ling,Chan Hoi-Yun,Tse Chi-Hang,Choi Paul Cheung-Lung,Chan Anthony Wing-Hung,Sung Joseph Jao-Yiu,Chan Henry Lik-Yuen

Publisher

Wiley

Subject

Hepatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/hep.23568/fullpdf

Reference37 articles.

1. Hepatocellular carcinoma and hepatitis B virus;Chan;Semin Liver Dis,2006

2. Hepatitis B e antigen and the risk of hepatocellular carcinoma;Yang;N Engl J Med,2002

3. Risk of hepatocellular carcinoma across a biologic gradient of serum hepatitis B virus DNA level;Chen;JAMA,2006

4. High viral load and hepatitis B virus subgenotype Ce are associated with increased risk of hepatocellular carcinoma;Chan;J Clin Oncol,2008

5. Lamivudine for patients with chronic hepatitis B and advanced liver disease;Liaw;N Engl J Med,2004

Cited by 104 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Impact of the Route and Schedule of Immunization on the Serological and Virological Response of Chronic Hepatitis B Patients Treated with HeberNasvac;Euroasian journal of hepato-gastroenterology;2023-12-22

2. Novel Drug Development in Chronic Hepatitis B Infection: Capsid Assembly Modulators and Nucleic Acid Polymers;Clinics in Liver Disease;2023-11

3. Hepatitis B Virus Epsilon (ε) RNA Element: Dynamic Regulator of Viral Replication and Attractive Therapeutic Target;Viruses;2023-09-12

4. Immune drivers of HBsAg loss in HBeAg-negative CHB patients after stopping nucleotide analog and administration of Peg-IFN;Hepatology Communications;2023-04-26

5. The role of different viral biomarkers on the management of chronic hepatitis B;Clinical and Molecular Hepatology;2023-04-01